OC
MRNA icon

Oakworth Capital’s Moderna MRNA Stock Holding History

Oakworth Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35K Hold
500
– – ﹤0.01% 517
2026
Q1 		$25.4K Hold
500
– – ﹤0.01% 548
2025
Q4 		$14.7K Hold
500
– – ﹤0.01% 612
2025
Q3 		$12.9K Buy
500
+450
+900% +$12.6K ﹤0.01% 607
2025
Q2 		$1.38K Buy
+50
New +$1.32K ﹤0.01% 585

Other funds holding MRNA

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Oakworth Capital's MRNA Position: Q2 2026 in Review

Oakworth Capital held its Moderna (MRNA) position steady in Q2 2026 at 500 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Oakworth Capital first reported a position in MRNA in Q2 2025 and has held it in 5 quarters since. 186 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Oakworth Capital held 500 shares of Moderna worth $35K as of Q2 2026.
  • Oakworth Capital left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Oakworth Capital's portfolio in Q2 2026, its #517 holding.
  • Oakworth Capital first reported a position in Moderna in Q2 2025 and has held it in 5 quarters since.
  • 186 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.